Tellimer logo
Search icon
Equity Analysis
/United States of America

US : InflaRx N.V. - IFRX | First Look at ANCA Vasculitis Data Suggests Vilobelimab is Active

    Contributors
    Ryan Deschner
    Timur Ivannikov
    CGS-CIMB
    12 May 2021
    Published by

    Watchlist

    Tellimer | Start Following

    Start following your markets today

    Follow your key analysts, markets and more so they appear here in your Watchlist - allowing you to keep an eye on the latest updates.